Cognitive Care Assistant

Over the past 3 months, the patient demonstrates stability in cognitive performance (±2% vs. baseline), accompanied by speech changes: increased mid-sentence pauses (+8%), mild word-finding latency on naming tasks, and speech rate within normal variance; movement changes include slightly reduced gait stability variability (−4% stride-time CV) with stable overall activity counts.

Physiological data indicates sleep patterns with modestly increased nocturnal awakenings (+0.4/night) but improved sleep efficiency (+3%) on weeks with consistent routines; activity level shows stable average daily movement with preserved HR variability during daytime blocks.

MRI-derived features show hippocampal volume mildly reduced for age; cortical thickness maps are unremarkable in frontal regions. Blood biomarker analysis indicates p-tau217 trending upward but still below the high-positive threshold on the last draw—repeat in 8–12 weeks is suggested.

🧠 Risk trajectory: longitudinal modeling shows a stable risk slope over the window, suggesting stability without clear progression on current data density—reassess after additional speech samples and one more sleep-thermal cycle.

⚡ Ultra-short summary: Cognitive trend stable with key drivers in speech pacing and sleep fragmentation. MRI: mild hippocampal signal; biomarkers: p-tau217 watch. Consistent with early MCI risk — monitor.